PROCOS S.P.A. (CBC Group)
Emilio Lamanuzzi is an experienced R&D researcher currently at PROCOS S.P.A. (CBC Group) since January 2020, specializing in scale-up and process safety, as well as analytical development. Key responsibilities include the development and pre-validation of analytical methods using techniques such as GC-FID, GC-MS, HPLC, and more, alongside performing various analyses like NMR and TGA. Previous roles include R&D Lab Technician and Research Trainee at Sun Chemical, focusing on ink formulations, and academic research at the Università degli Studi di Milano, culminating in a Master's thesis on vapor-liquid equilibrium. Emilio holds a Master's degree in Industrial Chemistry and a Bachelor's degree in Industrial Chemistry from the same university.
PROCOS S.P.A. (CBC Group)
Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry. Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA. We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.